.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
QuintilesIMS
Argus Health
AstraZeneca
Harvard Business School
Queensland Health
Healthtrust
Julphar
Johnson and Johnson
Federal Trade Commission

Generated: June 29, 2017

DrugPatentWatch Database Preview

Scopolamine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for scopolamine and what is the scope of scopolamine freedom to operate?

Scopolamine
is the generic ingredient in two branded drugs marketed by Perrigo Pharms Co and Glaxosmithkline Con, and is included in two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for scopolamine. Five suppliers are listed for this compound.

Summary for Generic Name: scopolamine

Tradenames:2
Patents:1
Applicants:2
NDAs:2
Drug Master File Entries: see list20
Suppliers / Packagers: see list5
Bulk Api Vendors: see list58
Clinical Trials: see list42
Patent Applications: see list5,868
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:scopolamine at DailyMed

Pharmacology for Ingredient: scopolamine

Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline Con
TRANSDERM SCOP
scopolamine
FILM, EXTENDED RELEASE;TRANSDERMAL017874-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe
Perrigo Pharms Co
SCOPOLAMINE
scopolamine
FILM, EXTENDED RELEASE;TRANSDERMAL078830-001Jan 30, 2015ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: scopolamine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Con
TRANSDERM SCOP
scopolamine
FILM, EXTENDED RELEASE;TRANSDERMAL017874-001Approved Prior to Jan 1, 19824,031,894► Subscribe
Glaxosmithkline Con
TRANSDERM SCOP
scopolamine
FILM, EXTENDED RELEASE;TRANSDERMAL017874-001Approved Prior to Jan 1, 19824,436,741► Subscribe
Glaxosmithkline Con
TRANSDERM SCOP
scopolamine
FILM, EXTENDED RELEASE;TRANSDERMAL017874-001Approved Prior to Jan 1, 19824,262,003► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Farmers Insurance
Citi
Accenture
Julphar
Johnson and Johnson
Moodys
Mallinckrodt
Teva
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot